Home›Questions on Notice›QoN 122

❓ Hon Nick Goiran asks about the catalyst, consultation process, concerns raised, and resolution of concerns regarding the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2025. The answer refers him to Commonwealth legislation and the Federal Register of Legislation.

AnsweredQoN 122Legislative Council

Asked

20 May 2025

Member

Hon Nick Goiran

Portfolio

Health

QuestionView source ↗

I refer to the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2025 , and I ask: (a) what was the catalyst for bringing about this determination; (b) who was consulted prior to this determination being finalised; (c) in reference to (b), did any person consulted raise any concerns; (d) if yes to (c), what were these concerns; (e) has the finalised determination addressed these concerns; and (f) if no to (e), why not?

AnswerView source ↗

Answered

24 June 2025

Responded by

Parliamentary Secretary to the Minister for Health

Response time

9 days

(a)–(f) This Determination was made under the Commonwealth Therapeutic Goods Legislation.
The purpose of, and consultation undertaken in relation to, each instrument is set out in the relevant explanatory statement for each instrument, available on the Federal Register of Legislation.

View on Parliament of WA